• Mashup Score: 0

    Purpose Patients with non-Hodgkin lymphoma (NHL) have a median age of 67, with 70% surviving over 5 years. Chemotherapy for aggressive NHL includes cyclophosphamide, anthracycline, and high doses of corticosteroids, which can impair bone health. By reviewing clinical characteristics and standard-of-care CT scans, we evaluate the prevalence and incidence of fractures and the clinical correlates of…

    Tweet Tweets with this article
    • Something new in #supponc. Increased risk of fractures after R-CHOP?! What would a prospective trial of intervention look like? #gerionc #geriheme ⁦@AndreasC466⁩ High incidence of fractures after R-CHOP-like chemotherapy for aggressive B-cell NHL https://t.co/CV8yRX264O